CC BY-NC-ND 4.0 · AJP Rep 2020; 10(03): e294-e299
DOI: 10.1055/s-0040-1716742
Case Report

Fetal Macrocephaly: A Novel Sonographic Finding in Congenital Myotonic Dystrophy

1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Ontario Fetal Centre, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada
,
Parry Balakumar
2   Undergraduate school, McGill University, Montreal, Quebec, Canada
,
Vibhuti Shah
3   Department of Paediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada
,
Karen Chong
4   Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada
,
Tami Uster
4   Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada
,
David Chitayat
4   Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada
5   Division of Clinical Genetics and Metabolism, Department of Pediatrics, University of Toronto, The Hospital for Sickkids, Toronto, Ontario, Canada
› Author Affiliations
Funding This research was nonfunded.

Abstract

Objective Sonographic clues to the diagnosis of congenital myotonic dystrophy (CDM) are limited, particularly in the absence of family history of myotonic dystrophy (DM). We reviewed cases of CDM for unique prenatal findings.

Study Design A single-center case series of fetuses with CMD with characteristic prenatal findings confirmed postnatally.

Results Four fetuses with pre- or postnatally diagnosed CDM presented with macrocephaly in utero. While head measurements were appropriate for gestational age until midgestation, third-trimester head circumference and biparietal diameter were both >2 standard deviation (SD) above the mean in all. Abdominal and femur measurements were otherwise appropriate for gestation. Postnatally, the occipitofrontal circumference was >2 SD above the mean in all, confirming the diagnosis of macrocephaly.

Conclusion CDM should be included in the differential diagnosis of third-trimester macrocephaly, especially in the presence of additional sonographic clues and when maternal medical history and physical examination are suggestive of DM.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.




Publication History

Received: 21 April 2020

Accepted: 04 June 2020

Article published online:
23 September 2020

© .

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

 
  • References

  • 1 Siciliano G, Manca M, Gennarelli M. et al. Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis. Clin Genet 2001; 59 (05) 344-349
  • 2 Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 2009; 132 (Pt 11): 3175-3186
  • 3 Esplin MS, Hallam S, Farrington PF, Nelson L, Byrne J, Ward K. Myotonic dystrophy is a significant cause of idiopathic polyhydramnios. Am J Obstet Gynecol 1998; 179 (04) 974-977
  • 4 Gutierrez Gutierrez G, Diaz-Manera J, Almendrote M. et al. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease. Neurologia 2020; 35 (03) 185-206
  • 5 Liquori CL, Ricker K, Moseley ML. et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001; 293 (5531): 864-867
  • 6 Campbell C, Levin S, Siu VM, Venance S, Jacob P. Congenital myotonic dystrophy: Canadian population-based surveillance study. J Pediatr 2013; 163 (01) 120-5.e1 , 3
  • 7 Darin N, Tulinius M. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord 2000; 10 (01) 1-9
  • 8 Pratte A, Prévost C, Puymirat J, Mathieu J. Anticipation in myotonic dystrophy type 1 parents with small CTG expansions. Am J Med Genet A 2015; 167A (04) 708-714
  • 9 Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 2012; 11 (10) 891-905
  • 10 Zaki M, Boyd PA, Impey L, Roberts A, Chamberlain P. Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome. Ultrasound Obstet Gynecol 2007; 29 (03) 284-288
  • 11 Hadlock FP, Deter RL, Harrist RB, Park SK. Estimating fetal age: computer-assisted analysis of multiple fetal growth parameters. Radiology 1984; 152 (02) 497-501
  • 12 WHO. WHO Child Growth Standards. Head circumference-for-age ac-f-a, triceps skinfold-for-age and subscapular skinfold-for-age. Methods and Development. Geneva, Switzerland, World Health Organization; 2007
  • 13 Regev R, de Vries LS, Heckmatt JZ, Dubowitz V. Cerebral ventricular dilation in congenital myotonic dystrophy. J Pediatr 1987; 111 (03) 372-376
  • 14 Bell DB, Smith DW. Myotonic dystrophy in the neonate. J Pediatr 1972; 81 (01) 83-86
  • 15 Garcia-Alix A, Cabañas F, Morales C. et al. Cerebral abnormalities in congenital myotonic dystrophy. Pediatr Neurol 1991; 7 (01) 28-32
  • 16 Mutchnick IS, Thatikunta MA, Gump WC, Stewart DL, Moriarty TM. Congenital myotonic dystrophy: ventriculomegaly and shunt considerations for the pediatric neurosurgeon. Childs Nerv Syst 2016; 32 (04) 609-616
  • 17 https://fetalmedicine.org/education/fetal-abnormalities/brain/macrocephaly . Accessed July 20, 2020